Article
A comparison of peginterferon α-2a and α-2b for treatment-naive patients with chronic hepatitis C virus: A meta-analysis of randomized trials.
Clinical therapeutics - 1 Aug 2010
Zhao Sihai, Liu Enqi, Chen Ping, Cheng Daxin, Lu Shemin, Yu Qi, Wang Yanli, Wei Kena, Yang Penghui
Abstract excerpt
BACKGROUND: The standard treatments for chronic infection with the hepatitis C virus (HCV) are peginterferon α-2a or α-2b plus ribavirin, but it remains unclear if one has a better efficacy and safety profile. OBJECTIVE: The aim of this study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing peginterferon α-2a and α-2b (in combination with ribavirin) treatments for chronic HCV....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
